Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral selenium supplementation for selenium-deficient patients with intestinal failure
jRCTs031220321Completed
- Sponsor
- Clinical Research Initiation-Fund (of Chiba University Hospital)
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of selenium in selenium deficiency and intestinal failure (IF), sponsored by Clinical Research Initiation-Fund (of Chiba University Hospital). Primary endpoint: Safety: adverse events related to oral selenium. Started Sep 2022; status: completed.
02
Drugs
selenium
03
Conditions
selenium deficiencyintestinal failure (IF)
Beyond the preview
Go deeper on jRCTs031220321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220321.